BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CeQur SA 

Rue Igor-Stravinsky 2
Case Postale 341
Montreux    1820  Switzerland
Phone: 41-21-9654646 Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
CeQur SA Appoints Douglas Lawrence Chief Executive Officer 4/10/2014 9:59:41 AM    More...
CeQur SA Release: Diabetes Care Publishes Data Demonstrating PaQ® Insulin Delivery Device Could Help People With Type 2 Diabetes Overcome Barriers To Insulin Adherence And Improve Clinical Outcomes 3/5/2014 10:08:44 AM    More...
CeQur SA To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/8/2014 7:12:33 AM    More...
CeQur SA Closes $27 Million Series B Financing 9/9/2013 7:05:54 AM    More...
CeQur SA Release: New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People With Type 2 Diabetes 6/24/2013 10:30:32 AM    More...
Positive Results for CeQur SA's PaQ® Insulin Delivery Device 3/1/2013 6:57:45 AM    More...
CeQur SA Announces Positive Results From Study Evaluating Simple Insulin Delivery Device Among People With Type 2 Diabetes 2/28/2013 11:30:15 AM    More...
CeQur SA Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides 12/11/2012 9:41:25 AM    More...
CeQur SA Receives CE Mark for PaQ® Insulin Delivery Device 11/27/2012 8:13:48 AM    More...
CeQur SA Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People With Type 2 Diabetes 9/26/2012 10:09:25 AM    More...
12